Stock A083790 CG INVITES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company CG Invites Co., Ltd.

Equities

A083790

KR7083790006

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 31/05/2024 am IST 		5-day change 1st Jan Change
2,435 KRW -0.20% Intraday chart for CG Invites Co., Ltd. -4.70% -12.25%
14/05 CG Invites Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
18/04 Hwail Pharmaceutical Co.,Ltd. announced that it has received KRW 19.0999977 billion in funding from Osung Advanced Materials Co., Ltd., Kumho HT, Inc., CrystalGenomics Invites Co., LTD. CI

Business Summary

CG Invites Co Ltd is a Korea-based company principally engaged in the development and manufacturing of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Research and Development segment is engaged in the research, development and sale of new drugs such as anti-inflammatory painkillers, anticancer drugs, anti-infectives and others. It is also engaged in the real estate rental business. The Pharmaceutical Manufacturing segment is engaged in the manufacture, retail and wholesale of finished drug products. The Other segment is engaged in the manufacture and sale of hot packs and other household items.

Number of employees: 68

Sales per Business

KRW in Million2022Weight2023Weight Delta
Drug Research and Development
374.5 %
17,606 45.6 % 18,272 374.5 % +3.78%
Inter-sectoral Adjustment
-292.2 %
-14,455 -37.4 % -14,256 -292.2 % -1.37%
Investment
17.7 %
598 1.5 % 863 17.7 % +44.37%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
87.8 %
38,564 99.8 % 4,281 87.8 % -88.90%
Overseas
12.2 %
78 0.2 % 597 12.2 % +667.42%

Managers

Managers TitleAgeSince
Joong-Myung Cho CEO
 Chief Executive Officer 75 01/00/01
Young-Joon Yoo AUD
 Comptroller/Controller/Auditor 52 -

Members of the board

Members of the board TitleAgeSince
Joong-Myung Cho CEO
 Chief Executive Officer 75 01/00/01
Jin-Woo Lee BRD
 Director/Board Member 59 31/17/31
Kyung-Sook Cho BRD
 Director/Board Member 64 -
Seung-Soo Shin BRD
 Director/Board Member 52 -
Jin-Gon Kim BRD
 Director/Board Member 60 -
Si-Young Song BRD
 Director/Board Member 66 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 15,000,000 0 0 57.55 %
Stock B 1 76,894,182 44,250,149 ( 57.55 %) 350,739 ( 0.4561 %)

Shareholders

NameEquities%Valuation
New Lake Investments Ltd.
34.92 %
26,850,089 34.92 % 58 M ₩
KUMHO HT, INC.
7.326 %
5,633,000 7.326 % 12 M ₩
Joong-Myung Cho
4.230 %
3,252,838 4.230 % 7 M ₩
CG INVITES CO., LTD.
2.392 %
1,839,483 2.392 % 4 M ₩
OSUNG ADVANCED MATERIALS CO., LTD.
1.951 %
1,500,000 1.951 % 3 M ₩
Sang-Chun Ahn
0.9190 %
706,651 0.9190 % 2 M ₩
Sang-geum Ahn
0.1601 %
123,142 0.1601 % 267 293 ₩
In-Chul Chung
0.1425 %
109,595 0.1425 % 237 888 ₩
Crystalgenomics, Inc. Employee Stock Ownership Assn.
0.0816 %
62,751 0.0816 % 136 208 ₩
Seung-Soo Shin
0.0520 %
40,000 0.0520 % 86 824 ₩

Holdings

NameEquities%Valuation
PANGEN BIOTECH INC.
16.68%
 1,903,405 16.68% 8,634,930 $
HWAIL PHARMACEUTICAL CO.,LTD.
5.70%
 3,791,240 5.70% 4,413,648 $
CG INVITES CO., LTD.
2.39%
 1,839,483 2.39% 3,992,800 $

Company contact information

CrystalGenomics Invites Co., Ltd.

5/F, Tower A, Korea Bio Park 700 Daewangpangyo-ro

13488, Seongnam-si

+

http://www.cginvites.com
address CG Invites Co., Ltd.(A083790)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
CG INVITES CO., LTD. Stock CG Invites Co., Ltd.
-12.25% 13Cr
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+40.73% 74TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.83% 60TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.30% 35TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.15% 32TCr
ABBVIE INC. Stock AbbVie Inc.
+4.05% 28TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.00% 24TCr
ROCHE HOLDING AG Stock Roche Holding AG
-5.52% 21TCr
AMGEN INC. Stock Amgen Inc.
+6.17% 16TCr
PFIZER, INC. Stock Pfizer, Inc.
-0.45% 16TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A083790 Stock
  4. Company CG Invites Co., Ltd.